Ruediger Siekmeier
Impact in
-
- Inhalation and Respiratory Drug Delivery
- Cystic Fibrosis Research Advances
-
- Antifungal resistance and susceptibility
Papers in
-
- Inhalation and Respiratory Drug Delivery 10
- Cystic Fibrosis Research Advances 3
-
- Antifungal resistance and susceptibility 3
- Co-authors
- G. Scheuch (8 shared papers)Peter Brand (4 shared papers)Martin J. Kohlhaeufl (1 shared paper)R. Horré (3 shared papers)Günter Marklein (2 shared papers)K. P. Schaal (1 shared paper)Norbert Schnitzler (1 shared paper)Sybren de Hoog (1 shared paper)
- Journals
- Respiration (2 papers)Advanced Drug Delivery Reviews (1 paper)Mycoses (1 paper)Therapeutic Delivery (1 paper)Experimental Lung Research (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Ruediger Siekmeier
16 papers receiving 557 citations
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 292
- Infectious Diseases 99
- Pharmaceutical Science 25
- Pharmacology 23
- Biomaterials 24
Countries citing papers authored by Ruediger Siekmeier
This map shows the geographic impact of Ruediger Siekmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Siekmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Siekmeier more than expected).
Fields of papers citing papers by Ruediger Siekmeier
This network shows the impact of papers produced by Ruediger Siekmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Siekmeier. The network helps show where Ruediger Siekmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruediger Siekmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 150 | |
| 2 | 2004 | 76 | |
| 3 | Novel approaches to enhance pulmonary delivery of proteins and peptides. | 2007 | 67 |
| 4 | 2002 | 47 | |
| 5 | 2008 | 45 | |
| 6 | Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of prospective studies. | 2011 | 40 |
| 7 | 2001 | 29 | |
| 8 | 2013 | 27 | |
| 9 | 2000 | 21 | |
| 10 | Treatment of systemic diseases by inhalation of biomolecule aerosols. | 2009 | 20 |
| 11 | Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods. | 2007 | 15 |
| 12 | 2010 | 15 | |
| 13 | 2010 | 15 | |
| 14 | 2003 | 12 | |
| 15 | Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. | 2007 | 11 |
| 16 | Aerosol therapy during non-invasive mechanical ventilation: Review of key technical factors and clinical implications | 2013 | 4 |
| 17 | 2010 | 2 | |
| 18 | 2008 | 0 |
About Ruediger Siekmeier
Ruediger Siekmeier is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Analytical Chemistry, Surgery and Epidemiology, having authored 18 papers that have together received 596 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (10 papers), Lipoproteins and Cardiovascular Health (4 papers), Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers), Cystic Fibrosis Research Advances (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (292 citations), Infectious Diseases (99 citations), Pharmaceutical Science (25 citations), Pharmacology (23 citations) and Biomaterials (24 citations). Ruediger Siekmeier has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include G. Scheuch, Peter Brand, Martin J. Kohlhaeufl, R. Horré, Günter Marklein, K. P. Schaal, Norbert Schnitzler, Sybren de Hoog, Tatjana Stojaković and Tanja B. Grammer. Their work appears in journals such as Respiration, Advanced Drug Delivery Reviews, Mycoses, Therapeutic Delivery and Experimental Lung Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.